Spot gold was little modified at $1,876.40 an oz. by 0938 GMT however was down 3.7% for the week, heading for its worst weekly loss since September after the preliminary vaccine euphoria dented safe-haven investor demand.
U.S. gold futures had been up 0.1% at $1,875.50.
“Gold has rebounded as a result of the pandemic and the COVID-19 numbers globally are nonetheless rising. The market optimism in direction of the vaccine and risk-on sentiment has light,” mentioned Financial institution of China Worldwide analyst Xiao Fu.
“There’s solely going to be a restricted variety of vaccines produced within the subsequent three months, even in 2021, however there might be different firms developing with vaccines as nicely. There might be different elements like mutation of the virus, the necessity to develop a brand new vaccine.”
Gold slumped 4.6% on Monday, its largest each day fall since Aug. 11, after drugmaker Pfizer and BioNTech SE mentioned their COVID-19 vaccine was greater than 90% efficient based mostly on preliminary trial outcomes.
U.S. Federal Reserve chairman Jay Powell and ECB President Christine Lagarde mentioned the economic system was nonetheless in for a troublesome time even when improvement of a possible vaccine was purpose for some optimism additional forward.
The greenback index held regular however was on monitor for a 0.7% weekly acquire.
In different treasured metals, silver edged 0.1% greater to $24.24 an oz., platinum rose 0.8% to $886.80 and palladium was up 0.7% at $2,348.43.
Disclaimer: This submit has been auto-published from an company feed with none modifications to the textual content and has not been reviewed by an editor